Principal Investigators on treatment protocols that involve an Investigational New Drug (IND ... FDA-regulated studies using investigational drugs or biologics (i.e., agents that require an IND ...
A new drug application is anticipated for 2029. The investigational new drug application for Zabalafin Hydrogel for the treatment of mild to moderate atopic dermatitis has been cleared by the FDA ...
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback